Cargando…

Hepatitis C virus infection: a challenge in the complex management of two cases of multidrug-resistant tuberculosis

BACKGROUND: Multidrug-resistant tuberculosis (MDR-TB) requires lengthy use of second-line drugs, burdened by many side effects. Hepatitis C virus (HCV) chronic infection increases risk of drug-induced liver injury (DILI) in these patients. Data on MDR-TB patients with concurrent HCV chronic infectio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Musso, Maria, Mosti, Silvia, Gualano, Gina, Mencarini, Paola, Urso, Rocco, Ghirga, Piero, Rianda, Alessia, Del Nonno, Franca, Goletti, Delia, Palmieri, Fabrizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6806539/ https://www.ncbi.nlm.nih.gov/pubmed/31640579 http://dx.doi.org/10.1186/s12879-019-4494-1

Ejemplares similares

Putting in harm to cure: Drug related adverse events do not affect outcome of patients receiving treatment for multidrug-resistant Tuberculosis. Experience from a tertiary hospital in Italy
por: Gualano, Gina, et al.
Publicado: (2019)

Active Pulmonary Tuberculosis in Elderly Patients: A 2016–2019 Retrospective Analysis from an Italian Referral Hospital
por: Di Gennaro, Francesco, et al.
Publicado: (2020)

Concurrent cavitary pulmonary tuberculosis and COVID-19 pneumonia with in vitro immune cell anergy
por: Musso, Maria, et al.
Publicado: (2021)

Usefulness of bronchoalveolar lavage in the management of patients presenting with lung infiltrates and suspect COVID-19-associated pneumonia: A case report
por: Gualano, Gina, et al.
Publicado: (2020)

Increased Association of Pulmonary Thromboembolism and Tuberculosis during COVID-19 Pandemic: Data from an Italian Infectious Disease Referral Hospital
por: Di Bari, Virginia, et al.
Publicado: (2022)

PMN-MDSC Frequency Discriminates Active Versus Latent Tuberculosis and Could Play a Role in Counteracting the Immune-Mediated Lung Damage in Active Disease
por: Grassi, Germana, et al.
Publicado: (2021)

Common and Rare Hematological Manifestations and Adverse Drug Events during Treatment of Active TB: A State of Art
por: Minardi, Maria Letizia, et al.
Publicado: (2021)

Patients with Tuberculosis Have a Dysfunctional Circulating B-Cell Compartment, Which Normalizes following Successful Treatment
por: Joosten, Simone A., et al.
Publicado: (2016)

Increase in Tuberculosis Diagnostic Delay during First Wave of the COVID-19 Pandemic: Data from an Italian Infectious Disease Referral Hospital
por: Di Gennaro, Francesco, et al.
Publicado: (2021)

Characterization of the immune impairment of patients with tuberculosis and COVID-19 coinfection
por: Najafi-Fard, Saeid, et al.
Publicado: (2023)

Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2
por: Petrone, Linda, et al.
Publicado: (2021)

Interplay of DDP4 and IP-10 as a Potential Mechanism for Cell Recruitment to Tuberculosis Lesions
por: Blauenfeldt, Thomas, et al.
Publicado: (2018)

Recovery from Triple Infection with SARS-CoV-2, RSV and Influenza virus: A case report
por: Guido, Giacomo, et al.
Publicado: (2023)

Pulmonary tuberculosis followed by sarcoidosis in an HIV-infected patient: A case report and a simplified diagnostic flowchart for diagnosis and treatment of sarcoidosis
por: Mencarini, P., et al.
Publicado: (2016)

Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patients
por: Aiello, Alessandra, et al.
Publicado: (2021)

Platelets accumulate in lung lesions of tuberculosis patients and inhibit T‐cell responses and Mycobacterium tuberculosis replication in macrophages
por: La Manna, Marco P., et al.
Publicado: (2022)

Multidrug-Resistant Tuberculosis In A Referral Center In Rome: 2011– 2016
por: Cannas, A, et al.
Publicado: (2019)

Quantitative and qualitative profiles of circulating monocytes may help identifying tuberculosis infection and disease stages
por: La Manna, Marco Pio, et al.
Publicado: (2017)

Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection
por: Petruccioli, Elisa, et al.
Publicado: (2021)

Antibiotics and Infectious Respiratory Diseases
por: Di Gennaro, Francesco, et al.
Publicado: (2022)

Detection of Pulmonary tuberculosis: comparing MR imaging with HRCT
por: Busi Rizzi, Elisa, et al.
Publicado: (2011)

New Antituberculosis Drugs: From Clinical Trial to Programmatic Use
por: Gualano, Gina, et al.
Publicado: (2016)

Effect of therapy on Quantiferon-Plus response in patients with active and latent tuberculosis infection
por: Petruccioli, Elisa, et al.
Publicado: (2018)

Accuracy of QuantiFERON SARS-CoV-2 research use only assay and characterization of the CD4(+) and CD8(+) T cell-SARS-CoV-2 response: comparison with a homemade interferon-γ release assay
por: Aiello, Alessandra, et al.
Publicado: (2022)

Impact of Vitamin D in Prophylaxis and Treatment in Tuberculosis Patients
por: Papagni, Roberta, et al.
Publicado: (2022)

Mycobacterium tuberculosis Immune Response in Patients With Immune-Mediated Inflammatory Disease
por: Petruccioli, Elisa, et al.
Publicado: (2021)

Transcriptional biomarkers for predicting development of tuberculosis: progress and clinical considerations
por: Esmail, Hanif, et al.
Publicado: (2020)

In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy
por: Petrone, Linda, et al.
Publicado: (2021)

Multidrug-Resistant Tuberculosis in Europe, 2010–2011
por: Günther, Gunar, et al.
Publicado: (2015)

Baricitinib Therapy in Covid-19 Pneumonia — An Unmet Need Fulfilled
por: Goletti, Delia, et al.
Publicado: (2021)

Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics
por: Cantini, Fabrizio, et al.
Publicado: (2017)

A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients
por: Petrone, Linda, et al.
Publicado: (2021)

Initial immune response after exposure to Mycobacterium tuberculosis or to SARS-COV-2: similarities and differences
por: Aiello, Alessandra, et al.
Publicado: (2023)

Tuberculosis Biomarkers: From Diagnosis to Protection
por: Goletti, Delia, et al.
Publicado: (2016)

Coordinated innate and T-cell immune responses in mild COVID-19 patients from household contacts of COVID-19 cases during the first pandemic wave
por: Aiello, Alessandra, et al.
Publicado: (2022)

Accuracy of QuantiFERON-TB Gold Test for Tuberculosis Diagnosis in Children
por: Sali, Michela, et al.
Publicado: (2015)

The definition of tuberculosis infection based on the spectrum of tuberculosis disease
por: Migliori, Giovanni Battista, et al.
Publicado: (2021)

Evaluation of the immunomodulatory effects of interleukin-10 on peripheral blood immune cells of COVID-19 patients: Implication for COVID-19 therapy
por: Najafi-Fard, Saeid, et al.
Publicado: (2022)

Socioeconomic status and biomedical risk factors in migrants and native tuberculosis patients in Italy
por: Pittalis, Silvia, et al.
Publicado: (2017)

Gated Calcium Ion Channel and Mutation Mechanisms in Multidrug-Resistant Tuberculosis
por: D’Elia, John A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tspale8snrhf43aombjktbbvsi